Corpus ID: 55612789

Thyroid function, assessed by thyroid stimulating hormone, and future risk of venous thromboembolism -The Tromsø study

@inproceedings{Lerstad2016ThyroidFA,
  title={Thyroid function, assessed by thyroid stimulating hormone, and future risk of venous thromboembolism -The Troms{\o} study},
  author={G. Lerstad and K. Enga and R. Jorde and E. Brodin and J. Svartberg and S. Br{\ae}kkan and J. Hansen},
  year={2016}
}
  • G. Lerstad, K. Enga, +4 authors J. Hansen
  • Published 2016
    • munin.uit.no

    Figures and Tables from this paper

    Figures and Tables

    References

    SHOWING 1-10 OF 33 REFERENCES
    The epidemiology of venous thromboembolism
    • 1,229
    • PDF
    Acute Infections and Venous Thromboembolism
    • 40
    Increased levels of free thyroxine and risk of venous thrombosis in a large population‐based prospective study
    • 27
    Evaluation of the respective influence of thyroid hormones and TSH on blood coagulation parameters after total thyroidectomy.
    • 32
    • PDF
    Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control study.
    • 60
    • PDF
    Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø study
    • 217
    Risk of deep venous thrombosis (DVT) in bedridden or wheelchair-bound multiple sclerosis patients: a prospective study.
    • 37
    The effect of changes in thyroxine and thyroid‐stimulating hormone levels on the coagulation system
    • 27
    • PDF
    Abdominal obesity is essential for the risk of venous thromboembolism in the metabolic syndrome: the Tromsø study
    • 66
    Venous Thromboembolism in Patients Hospitalized With Thyroid Dysfunction
    • Liviu G. Danescu, Aaref Badshah, +6 authors P. Stein
    • Medicine
    • Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    • 2009
    • 43